Health & bio
GLP-1 Oral Formulation Prescribed to 170K Patients in Six Weeks
The adoption curve for orals is outpacing injectables' initial trajectory, marking a paradigm shift in obesity treatment delivery.
Primary sources · 1
The adoption curve for orals is outpacing injectables' initial trajectory, marking a paradigm shift in obesity treatment delivery.
7 must-reads · 17 fields · tracked storylines delivered to your inbox daily. Pick only the fields you want; unsubscribe anytime.